Key Anti-Aging Drugs Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The anti-aging drugs market is very competitive and is driven by the key pharmaceutical, cosmeceutical, and biotech players. Firms such as AbbVie, Novartis, and GSK are actively investing in cellular rejuvenation, NAD+ pathway modulation, and senolytics. Strategic partnerships, including Pfizer’s collaboration with biotech startups and investments by Alphabet’s Calico, further fuel the R&D innovation. Companies in Asia are increasing in both modern and traditional bioactive compounds. Companies in India are aiming for biosimilar-related aging therapies to broaden access with cost effective therapies.
Here is a list of key players operating in the anti-aging drugs market:
|
Company Name |
Country of Origin |
Market Share (Approx., 2024) |
|
AbbVie Inc. |
U.S. |
10.1% |
|
L’Oréal S.A. (Active Cosmetics Division) |
France |
6.8% |
|
Johnson & Johnson |
U.S. |
6.5% |
|
Pfizer Inc. |
U.S. |
6.2% |
|
Bayer AG |
Germany |
5.9% |
|
GlaxoSmithKline (GSK) |
UK |
xx% |
|
Novartis AG |
Switzerland |
xx% |
|
Amorepacific Corporation |
South Korea |
xx% |
|
Rejuvenate Bio |
U.S. |
xx% |
|
Eisai Co., Ltd. |
Japan |
xx% |
|
Dr. Reddy's Laboratories |
India |
xx% |
|
Calico Life Sciences (Alphabet Inc.) |
U.S. |
xx% |
|
Evolus, Inc. |
U.S. |
xx% |
|
Medytox, Inc. |
South Korea |
xx% |
|
CSL Limited |
Australia |
xx% |
|
Hims & Hers Health, Inc. |
U.S. |
xx% |
|
Lupin Limited |
India |
xx% |
|
Biocon Biologics |
India |
xx% |
|
Forest Biosciences |
Malaysia |
xx% |
|
Chugai Pharmaceutical Co., Ltd. (Roche Subsidiary) |
Japan |
xx% |
Below are the areas covered for each company in the market:
